Skip to content
ClinCalc Pro
Menu
Second-generation cephalosporin

Cefaclor

Brand names: Distaclor

Cefaclor is an oral second-generation cephalosporin antibiotic used for susceptible respiratory, urinary and skin infections.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is bactericidal, binding penicillin-binding proteins to inhibit bacterial cell-wall synthesis and cause cell lysis.

Prescribing in practice

  • Avoid in patients with a history of immediate hypersensitivity to penicillins or cephalosporins, as cross-reactivity can cause serious allergic reactions.
  • A serum-sickness-like reaction with rash and arthralgia is recognised, particularly in children, and should prompt discontinuation.
  • As with other broad-spectrum antibiotics, it can precipitate Clostridioides difficile infection.

Monitoring

Routine laboratory monitoring is not required; review clinical response and watch for hypersensitivity or new diarrhoea.

Counselling the patient

  • Complete the full prescribed course even once you feel better.
  • Stop and seek urgent advice if you develop a rash, joint pains, swelling or breathing difficulty.
  • Report severe or persistent diarrhoea rather than treating it yourself.

Evidence & guidelines

Cefaclor is a long-established oral cephalosporin with efficacy supported by extensive clinical use and the SPC.

Reference: NICE CKS; BSAC; UKHSA AMR; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.